Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access - HealthTree for Myeloma
Seattle Inno - Adaptive Biotechnologies to receive up to $250M in financing deal
Adaptive Biotechnologies Corp. - 6/26/2019 | TD Cowen
Adaptive Biotechnologies Corp. : Graphique de cours statique | | | Zonebourse
Adaptive Biotechnologies: Getting Closer To The 'Buy Zone' (NASDAQ:ADPT) | Seeking Alpha
Adaptive Biotechnologies and Microsoft launch virtual ImmuneRACE study to inform novel COVID-19 diagnostics to address unmet needs in testing - Stories
Adaptive Biotechnologies Corporation Insider Trading & Ownership Structure - Simply Wall St
Adaptive Biotechnologies Corp. | LinkedIn
Adaptive Biotechnologies Corp. on LinkedIn: We're proud to be a finalist for the 2023 GeekWire Awards in the…
Adaptive Biotechnologies Corp (ADPT) | Finance information
Avis des salariés sur l'entreprise Adaptive Biotechnologies Corp. | Speak & Act
First Quarter 2022
Powering the Age of Immune Medicine - Adaptive Biotech
Adaptive Biotechnologies | BIO
Adaptive Biotechnologies buys Sequenta to expedite cancer, infectious disease treatments – GeekWire
Adaptive Biotechnologies Corporation : Cotation Bourse Action | ADPT | US00650F1093 | Zonebourse
Adaptive Biotechnologies terminates chief operating officer - Puget Sound Business Journal
Tech Moves: Adaptive Biotech co-founders join life sciences SPAC; new edtech execs; and more – GeekWire
Adaptive Biotechnologies | The Conference Forum
SEC Filing | Adaptive Biotechnologies
6,186/6,446) Adaptive Biotechnologies Corp.
This Day That Year: Adaptive Biotechnologies (ADPT)
Adaptive Biotechnologies Corp Shares Close the Day 13.1% Lower - Daily Wrap | Nasdaq
Adaptive Biotechnologies To Lay Off ~12% Of Its Workforce, Names Tycho Peterson As CFO
Articles about Adaptive Biotechnologies
Morgan Stanley Maintains Adaptive Biotechnologies (ADPT) Equal-Weight Recommendation
6,186/6,446) Adaptive Biotechnologies Corp.
